Development Of Antibody Immobilisation Strategy Using Recombinant Human Neonatal Fc Receptor

dc.contributor.authorNg, Woei Kean
dc.date.accessioned2019-08-27T01:52:48Z
dc.date.available2019-08-27T01:52:48Z
dc.date.issued2017-08
dc.description.abstractAntibody immobilisation is the cornerstone of antibody-based assay in biosensing technology which is predominantly used to detect and measure a wide variety of biological analytes, ranging from antigens, biomarkers, allergens and drug substances. As such, specific interactions between antibody and ligands are therefore needed to guarantee highest reproducibility and sensitivity possible. The complexity of pinning antibodies forms the key factor in interfering the outcome of an assay as the recognition molecule, i.e. the antibody itself, may have undergone structural changes and distortion when it is attached to the solid phase. In view of this, there is a need to identify new methods and novel strategy in immobilising antibody to secure the biosensing system. The present study sought to discover a new candidate of antibody binding protein, the human neonatal Fc receptor. This protein has shown its high affinity specifically towards Fc region of antibody either in vivo or in vitro. It is a heterodimer constructed of two subunits: p51 α-heavy chain (α-chain) and the β2-microglobulin light chain. Literatures have revealed its binding sites towards antibody and all of the residues involved are solely found in the α-chain. As a result, the α-chain alone was used for antibody immobilisation in the present study. The cDNA encoding for the α-chain of human neonatal Fc receptor (hFcRn-α) was cloned into a bacterial expression vector. Attempts had been made to express the soluble form of human neonatal Fc receptor in bacteria instead of the conventional approach which uses mammalian cells. The addition of betaine with a brief heat shock step during cultivation had successfully enhanced the solubility of recombinant protein expressed.en_US
dc.identifier.urihttp://hdl.handle.net/123456789/8675
dc.language.isoenen_US
dc.publisherUniversiti Sains Malaysiaen_US
dc.subjectDevelopment of antibody immobilisation strategyen_US
dc.subjectusing recombinant human neonatal Fc receptoren_US
dc.titleDevelopment Of Antibody Immobilisation Strategy Using Recombinant Human Neonatal Fc Receptoren_US
dc.typeThesisen_US
Files
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: